安飛士 CAR 深 滬
已收盤 12-19 16:00:00 美东时间
130.59
+2.480
+1.94%
華盛通- 最 高132.58
- 今 開127.92
- 成交量 76.25万股
- 最 低 127.36
- 昨 收 128.11
- 總市值 45.96亿
- 52周最高 212.81
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 54.03
- 委 比 -84.91%
- 總股本 3519.70万
- 歷史最高 535.11
- 量 比 0.96
- 振 幅 4.07%
- 歷史最低 -3.65
- 每 手 1
- 風險率 38.42%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Quadruple witching day: Brace for market volatility
Expect market volatility on Friday on account of quadruple witching - meaning stock index futures, stock index options, stock options, and single stock futures will expire simultaneously. While Decemb...
12-19 19:23
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
12-09 10:32
Morgan Stanley Downgrades Avis Budget Gr to Equal-Weight, Raises Price Target to $142
Morgan Stanley analyst Adam Jonas downgrades Avis Budget Gr (NASDAQ:CAR) from Overweight to Equal-Weight and raises the price target from $115 to $142.
12-09 00:59
Tesla's Robotaxi Revolution Is Still Downloading — Waymo's Already In The Fast Lane
Waymo is quietly launching self-driving cars in multiple cities while Tesla's robotaxi plans remain in regulatory limbo, impacting Musk's compensation and market share.
11-13 21:27
CARISMA Therapeutics Q3 EPS $1.07 Beats $(0.12) Estimate, Sales $45.250M Beat $3.771M Estimate
CARISMA Therapeutics (NASDAQ:CARM) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $(0.12) by 991.67 percent. This is a 445.16 percent increase over losses of $(0.31) per share
11-13 06:50
Rivian's 25% Stock Rally Puts EV ETFs Back In Play—Time to Buy?
Rivian stock jumped over 25% Wednesday after strong Q3 results, lifting EV ETFs after yesterday's dip. Is it a good time to buy these funds?
11-06 03:51
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
11-04 10:31
